Publications by authors named "Philip Debruyne"

Claim this Profile
A
A Multi-Center Comparative Analysis of the G8-Score and Charlson Comorbidity Index as General Health Assessment Tools in Older Patients With Prostate Cancer.
Brecht Chys, Philip R Debruyne, Lore Decoster, Cindy Kenis, Hans Wildiers

Clin Genitourin Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.
Kristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem, Christian U Blank, Irene Reijers, Philip R Debruyne

Cancer Res Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Tele-Music Interventions in Supportive Cancer Care: A Systematic Review.
Lore Mertens, Laura Tack, Tom Boterberg, Jörg Fachner, Leonardo Muller-Rodriguez, Philip R Debruyne

Brain Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nemvaleukin alfa monotherapy in patients with advanced melanoma and renal cell carcinoma: results from the phase 1/2 non-randomized ARTISTRY-1 trial.
Emiliano Calvo, Valentina Boni, Olivier Dumas, Sang Joon Shin, Seth D Rosen, Philip R Debruyne

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Fear of Cancer Recurrence with Internet-Based Emotional Freedom Techniques (iEFT) and Mindfulness Meditation Intervention (iMMI) (BGOG-gyn1b/REMOTE).
Laura Tack, Lore Mertens, Marte Vandeweyer, Fien Florin, Emma Pauwels, Philip R Debruyne

Brain Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: should we treat beyond two years?
Alexander Decruyenaere, Gennigens Christine, Rottey Sylvie, Laenen Annouschka, Emmanuel Seront, Philip R Debruyne

Acta Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial.
Alicia F C Okines, Giuseppe Curigliano, Nobumasa Mizuno, Do-Youn Oh, Andree Rorive, Philip R Debruyne

Nat Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study.
Erika Hamilton, Matthew D Galsky, Sebastian Ochsenreither, Gianluca Del Conte, Miguel Martín, Philip R Debruyne

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating pain management practices for cancer patients among health professionals in cancer and supportive/palliative care units: a Belgian survey.
Christel Fontaine, Isabelle Libert, Marie-Aline Echterbille, Vincent Bonhomme, Jacky Botterman, Philip R Debruyne

Support Care Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab.
Yana Beulque, Lisa Kinget, Eduard Roussel, Sajedeh Mobaraki, Annouschka Laenen, Philip R Debruyne

Acta Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.
Marieke van Leeuwen, Jacobien M Kieffer, Teresa E Young, Maria Antonietta Annunziata, Volker Arndt, Philip R Debruyne

J Cancer Surviv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudoprogression and Mixed Responses in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab: A Retrospective Analysis.
Lorenz Haaker, Marcella Baldewijns, Liesbeth De Wever, Maarten Albersen, Philip R Debruyne

Clin Genitourin Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term health-care utilisation in older patients with cancer and the association with the Geriatric 8 screening tool: a retrospective analysis using linked clinical and population-based data in Belgium.
Victoria Depoorter, Katrijn Vanschoenbeek, Lore Decoster, Geert Silversmit, Philip R Debruyne

Lancet Healthy Longev· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End-of-Life Care in the Last Three Months before Death in Older Patients with Cancer in Belgium: A Large Retrospective Cohort Study Using Data Linkage.
Victoria Depoorter, Katrijn Vanschoenbeek, Lore Decoster, Geert Silversmit, Philip R Debruyne

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.
Victoria Depoorter, Katrijn Vanschoenbeek, Lore Decoster, Harlinde De Schutter, Philip R Debruyne

J Geriatr Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Clinical cancer research in vulnerable populations.
Laura Tack, Patricia Schofield, Tom Boterberg, Christopher N Parris, Philip R Debruyne

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Performance of Screening Tools for Depressive Symptoms in Vulnerable Older Patients with Cancer Undergoing Comprehensive Geriatric Assessment (CGA): Results from the SCREEN Pilot Study.
Laura Tack, Ann-Sophie Maenhoudt, Lore Ketelaars, Jolien De Zutter, Stefanie Pinson, Philip R Debruyne

Curr Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Implementation of the Comprehensive Geriatric Assessment to Optimise Care for Older Adults with Cancer.
Laura Tack, Patricia Schofield, Tom Boterberg, Rebecca Chandler, Christopher N Parris, Philip R Debruyne

Geriatrics (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study.
Glen Meert, Cindy Kenis, Koen Milisen, Philip R Debruyne, Inge De Groof

J Geriatr Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter study.
Cindy Kenis, Lore Decoster, Johan Flamaing, Philip R Debruyne, Inge De Groof

BMC Geriatr· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychosocial Care after Cancer Diagnosis: Recent Advances and Challenges.
Laura Tack, Patricia Schofield, Tom Boterberg, Rebecca Chandler, Christopher N Parris, Philip R Debruyne

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study.
Sofie Demasure, Isabel Spriet, Philip R Debruyne, Annouschka Laenen, Wim Wynendaele

Acta Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial.
Rachel Galot, Christophe Le Tourneau, Esma Saada-Bouzid, Amaury Daste, Caroline Even, Philip Debruyne

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised wait-list controlled trial to evaluate Emotional Freedom Techniques for self-reported cancer-related cognitive impairment in cancer survivors (EMOTICON).
Laura Tack, Tessa Lefebvre, Michelle Lycke, Chistine Langenaeken, Christel Fontaine, Philip R Debruyne

EClinicalMedicine· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic Home-Hospitalization Delivers a High-Quality and Patient-Centered Alternative to Standard Ambulatory Care: Results of a Randomized-Controlled Equivalence Trial.
Lieselot Cool, Jana Missiaen, Philip Debruyne, Hans Pottel, Veerle Foulon

JCO Glob Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis